What are the Historical and Forecasted Market Sizes of the Chorionic Gonadotropin Global Market Report 2025?
The chorionic gonadotropin market size has demonstrated consistent growth over recent years and is projected to increase from $1,260 million in 2024 to $1,340 million in 2025 at a compound annual growth rate (CAGR) of 4.4%. Factors contributing to this growth include increased awareness of hCG among healthcare professionals and patients, heightened utilization for the treatment of hormonal imbalance disorders, enhanced affordability, improvements in healthcare facilities, and growing demand for assisted reproduction.
Looking towards the future, the market size is forecasted to reach $1,710 million in 2029 with CAGR of 4%. Growth drivers include the increasing prevalence of infertility issues, rising awareness about reproductive health, expanding adoption of assisted reproductive technologies, growing incidence of hypogonadism among the elderly, and developing healthcare infrastructure. Major market trends include technological advancements, progress in recombinant technology, growth in assisted reproductive technology, increased investments in research and development, and innovations in drug delivery systems and formulations.
Get Your Free Sample of The Global Chorionic Gonadotropin Global Market Report 2025 Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19888&type=smp
What Are Key Growth Drivers in the Chorionic Gonadotropin Market?
An increasing prevalence of infertility issues worldwide is anticipated to drive the growth of the chorionic gonadotropin market. Infertility is challenging for a significant portion of the population, mainly due to delayed childbearing and unfavorable lifestyle factors like obesity and smoking. Human Chorionic Gonadotropin (hCG) serves as a treatment to enhance ovulation in women, maintain pregnancy, and boost testosterone production in men, thus improving sperm count and addressing various infertility issues.
Further propelling the market growth is the proliferation of Assisted Reproductive Technologies (ART). As infertility rates rise and medical advancements improve, more individuals and couples are resorting to ART to conceive. Chorionic Gonadotropin (hCG) is critical in ART, triggering ovulation and supporting the early stages of pregnancy after embryonic transfer.
What are the Major Segments in the Chorionic Gonadotropin Market?
— By Type: Human Chorionic Gonadotropin; Animal Chorionic Gonadotropin
— By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
— By Therapeutic Application: Male Hypogonadism; Female Infertility Treatment; Oligospermic Treatment; Cryptorchidism Treatment; Chronic Pain; Other Therapeutic Applications
— By End User: Research Institutions; Pharmaceutical Companies
Order your report now for swift delivery:
https://www.thebusinessresearchcompany.com/report/chorionic-gonadotropin-global-market-report
Which Companies Are Driving the Chorionic Gonadotropin Market?
Ferring Pharmaceuticals is among the notable players operating in the chorionic gonadotropin market.
What Current Trends are Emerging in the Chorionic Gonadotropin Market?
The focus on developing innovative solutions, such as saliva-based pregnancy tests, signals a major market trend. These tests offer greater convenience, accuracy, and accessibility by detecting hCG in a woman’s saliva. For instance, in June 2023, Israel-based biotech company Salignostics launched the world’s first saliva-based pregnancy test, Salistick, which enhances the testing experience and delivers results within 5 to 15 minutes.
What Regions Are Dominating and Growing Fast in the Chorionic Gonadotropin Market?
In 2024, North America was the largest region in the chorionic gonadotropin market. The fastest-growing region in the forecast period is expected to be Asia-Pacific.
What Does The Chorionic Gonadotropin Global Market Report 2025 Offer?
Chorionic gonadotropin, specifically human chorionic gonadotropin (hCG), is a hormone produced by the placenta during pregnancy. It supports the corpus luteum to maintain progesterone levels and is used to induce ovulation in women, treat hypogonadism in men, and as a tumor marker for certain cancers. The Chorionic Gonadotropin Global Market Report 2025 research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19888
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
